Studies have shown low IGF‐1 in patients with T1D, which could indirectly affect bone turnover.(13, 14, 15) With impaired endogenous secretion, portal levels of insulin are low in T1D whereas the exogenous insulin results in peripheral hyperinsulinemia. This evidence concerns the gene INS and hyperinsulinism.